Literature DB >> 10556125

Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation.

M Confalonieri1, A Potena, G Carbone, R D Porta, E A Tolley, G Umberto Meduri.   

Abstract

In uncontrolled studies, noninvasive positive pressure ventilation (NPPV) was found useful in avoiding endotracheal intubation in patients with acute respiratory failure (ARF) caused by severe community-acquired pneumonia (CAP). We conducted a prospective, randomized study comparing standard treatment plus NPPV delivered through a face mask to standard treatment alone in patients with severe CAP and ARF. Patients fitting the American Thoracic Society criteria for severe CAP were included in presence of ARF (refractory hypoxemia and/or hypercapnia with acidosis). Exclusion criteria were: severe hemodynamic instability, requirement for emergent cardiopulmonary resuscitation, home mechanical ventilation or oxygen long-term supplementation, concomitant severe disease with a low expectation of life, inability to expectorate or contraindications to the use of the mask. Fifty-six consecutive patients (28 in each arm) were enrolled, and the two groups were similar at study entry. The use of NPPV was well tolerated, safe, and associated with a significant reduction in respiratory rate, need for endotracheal intubation (21% versus 50%; p = 0.03), and duration of intensive care unit (ICU) stay (1.8 +/- 0.7 d versus 6 +/- 1.8 d; p = 0.04). The two groups had a similar intensity of nursing care workload, time interval from study entry to endotracheal intubation, duration of hospitalization, and hospital mortality. Among patients with chronic obstructive pulmonary disease (COPD), those randomized to NPPV had a lower intensity of nursing care workload (p = 0.04) and improved 2-mo survival (88.9% versus 37.5%; p = 0.05). We conclude that in selected patients with ARF caused by severe CAP, NPPV was associated with a significant reduction in the rate of endotracheal intubation and duration of ICU stay. A 2-mo survival advantage was seen in patients with COPD.

Entities:  

Mesh:

Year:  1999        PMID: 10556125     DOI: 10.1164/ajrccm.160.5.9903015

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  113 in total

Review 1.  International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Organised jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Société de Réanimation de Langue Française, and approved by the ATS Board of Directors, December 2000.

Authors:  T W Evans
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Non-invasive ventilation in acute respiratory failure.

Authors: 
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

Review 4.  The pulmonary physician in critical care . 3: critical care management of community acquired pneumonia.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

5.  Non-invasive pressure support ventilation in acute hypoxemic respiratory failure: common strategy for different pathologies?

Authors:  Stefano Nava; Annalisa Carlucci
Journal:  Intensive Care Med       Date:  2002-09       Impact factor: 17.440

Review 6.  Pulmonary infiltrates in the immunocompromised: diagnosis and management.

Authors:  D Peckham; M W Elliott
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 7.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

8.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

9.  Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure.

Authors:  Jason Phua; Kien Kong; Kang Hoe Lee; Liang Shen; T K Lim
Journal:  Intensive Care Med       Date:  2005-03-02       Impact factor: 17.440

10.  Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia.

Authors:  Anna Maria Brambilla; Stefano Aliberti; Elena Prina; Francesco Nicoli; Manuela Del Forno; Stefano Nava; Giovanni Ferrari; Francesco Corradi; Paolo Pelosi; Angelo Bignamini; Paolo Tarsia; Roberto Cosentini
Journal:  Intensive Care Med       Date:  2014-05-10       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.